{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001567264","name":"INTENSITY THERAPEUTICS, INC.","summary":"Intensity Therapeutics, Inc. is a late-stage clinical biotechnology company focused on intratumoral (IT) cancer treatment. Its lead product candidate, INT230-6, combines cisplatin, vinblastine sulfate, and an amphiphilic molecule (SHAO) to disperse cytotoxic agents directly into solid tumors. The company is conducting Phase 3 trials in soft tissue sarcoma (INVINCIBLE-3) and Phase 2 trials in triple-negative breast cancer (INVINCIBLE-4), aiming to achieve local tumor killing and systemic immune activation.","people":[],"products":[{"name":"INT230-6","type":"platform","description":"Intratumoral injection comprising cisplatin, vinblastine sulfate, and amphiphilic molecule SHAO to disperse cytotoxic agents throughout solid tumors and activate systemic anti-cancer immunity."},{"name":"DfuseRx SM","type":"platform","description":"Discovery platform used to create amphiphilic-based anti-cancer product candidates for direct intratumoral injection."}],"partnerships":[{"partner_name":"Merck","partnership_type":"development","description":"INT230-6 tested in combination with Merck's Keytruda (pembrolizumab) in the Phase 1/2 IT-01 Study.","start_date":null},{"partner_name":"Bristol Myers Squibb","partnership_type":"development","description":"INT230-6 tested in combination with BMS's Yervoy (ipilimumab) in the Phase 1/2 IT-01 Study.","start_date":null},{"partner_name":"Swiss Cancer Group (SCI)","partnership_type":"development","description":"Collaboration to conduct the INVINCIBLE-4 Phase 2 study treating localized triple-negative breast cancer patients.","start_date":null}],"affiliations":[],"origin":{"leaf":"928ce43113df309c5ce90aa0aac27d2317c0a45b1af3a9f7797769ce214256aa","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"8ae48e96cce62dc49f8ef8f31def91e37659639f6aa1540d6ea34800ae02e40f","parent":"3182d6afc6abfe5fb0e43c02e0bba211479972495ce2472362ea7617bbc0b16b","source":"0001567264-26-000024","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":22,"hourly_limit":500,"remaining":478,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}